GENERIC DRUG substitution should be a no-brainer when the innovator patent has expired and there is a cheaper generic launched. Brand Pharma companies have long enjoyed, and in cases actively contributed to, the urban myth that the generic is somehow inferior. The FDA has a stringent process for generic drug approval and this debate is groundless. Unless you happen to be the innovator.
http://lnkd.in/wkg7xn
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022